Scientists in Cambridge, Mass. and Chennai, India, are touting self-organizing brain tissue growth in a 3D-printed system. Published results in Biomicrofluidics highlight the work of the Massachusetts Institute of Technology (MIT) and Indian Institute of Technology Madras scientists, who have grown small amounts of the self-organizing brain tissue, known as organoids, in a tiny 3D-printed system that […]
Neurological
Pear Therapeutics inks multiple agreements to expand digital therapeutic platform
Pear Therapeutics announced today that it entered into multiple agreements to bolster its prescription digital therapeutics (PDT) platform. Boston-based Pear Therapeutics’ agreements are set to add to its library of digital biomarkers, machine learning algorithms, sensor-based technologies and digital therapeutics, according to a news release. Get the full story at our sister site, Drug Delivery […]
Seelos, Aptar sign deal for Bidose system to deliver ketamine candidate
Seelos Therapeutics (NSDQ:SEEL) announced today that it partnered with AptarGroup (NYSE:ATR) for the Bidose liquid system device. The agreement includes the co-exclusive use and supply of Aptar Pharma’s Bidose device for the delivery of Seelos’ intranasal ketamine product candidate, SLS-002, for treating suicidality, depression and post-traumatic stress disorder (PTSD). Get the full story at our sister site, Drug […]
Nevro touts data supporting use of Senza system to treat diabetic neuropathy pain
Nevro (NYSE:NVRO) today touted results from a trial of its Senza system for treating painful diabetic neuropathy (PDN)-related chronic pain. Redwood City, Calif.-based Nevro, which published the results of the SENZA-PDN trial in JAMA Neurology, said in a news release that, if approved, the Senza spinal cord stimulation (SCS) system would be the first FDA-approved […]
BrainsWay raises more than $45M
BrainsWay recently announced that it closed an underwritten public offering worth approximately $45.2 million in proceeds. The non-invasive brain disorder treatment developer offered more than 5.3 million American Depositary Shares (ADSs), upsized to include 693,300 ADSs sold pursuant to the underwriters’ exercise in full of their option to purchase additional shares at $8.50 per share, […]
NeuroPace files for $75M IPO
Refractory focal epilepsy treatment developer NeuroPace last week filed with the SEC to raise up to $75 million in an initial public offering. Mountain View, Calif-based NeuroPace develops the RNS system, which it touts as the world’s only closed-loop brain-responsive neurostimulation system designed to prevent seizures at their source. The RNS system includes a neurostimulator, […]
Helius Medical wins FDA nod for tongue stimulator that improves MS patients’ gait
The FDA announced today that it authorized marketing for a stimulator device that treats gait deficit in those with multiple sclerosis (MS). Helius Medical’s portable neuromodulation stimulator (PoNS) is a neuromuscular tongue stimulator that uses a non-implantable apparatus to generate electrical pulses for stimulation of the trigeminal and facial nerves via the tongue to treat […]
BrainScope launches next-gen concussion diagnostic device
BrainScope announced that it launched its third FDA-cleared algorithm for concussion diagnosis on the BrainScope device. Bethesda, Md.–based BrainScope’s Concussion Index is the first physiological marker of concussive injury that aids clinicians in the assessment of patients at baseline, point of injury and through recovery, according to a news release. The index adds to BrainScope’s […]
Racial disparities remain despite increased mechanical clot removal in stroke patients
Data presented at the American Stroke Association’s International Stroke Conference 2021 shows that racial disparities persist in stroke treatment. According to a news release, mechanical removal of blood clots causing a stroke is increasing, but there remain racial differences in the treatment, a study shows. Get the full story at our sister site, Medical Design […]
Viz.ai raises $71 million Series C, touts positive data for stroke care outcomes
Artificial intelligence platform developer Viz.ai announced that it raised $71 million in a Series C financing round. San Francisco-based Viz.ai develops AI software for treating acute ischemic stroke. The software uses a computer-aided triage system to identify a suspected large-vessel occlusion via CT scan and alerts a stroke team specialist to reduce the time to […]
MagVenture launches brain stimulation clinical positioning system
MagVenture announced today that it launched the patent-pending MagVenture Flow Arm for brain stimulation positioning. Alpharetta, Ga.–based MagVenture’s Flow Arm clinical positioning system is designed to optimize the delivery of the company’s FDA-cleared protocols for non-invasive brain stimulation technology in treating major depressive disorder and as an adjunct therapy for OCD, according to a news […]
